Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
1/1/2000
1.
Phase II Randomized Study Comparing Immunologic Responses of Stage II and III Colorectal Cancer Patients on Adjuvant Therapy Treated with 3H1 Anti-Idiotype Monoclonal Antibody Mixed with Sargramostim Versus 3H1 Anti-Idiotype Monoclonal Antibody Alum Precipitate Mixed with Sargramostim (Summary Last Modified 01/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
UKMC-95GI24CB
NCI-H97-1184
Last Modified:
4/20/2007
2.
Phase II Study of Vaccine Therapy With Tumor-Specific Mutated Ras Peptides in Combination With Interleukin-2 and/or Sargramostim (GM-CSF) in Adults With Metastatic Solid Tumors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
NCI-97-C-0141F
NCI-T96-0078, T96-0078, NCT00019331
Last Modified:
4/20/2007
3.
Phase I Study of Carcinoembryonic Antigen Peptide-1 (CAP) and DetoxPC for Adenocarcinomas of the Gastrointestinal Tract, Breast, and Lung (Summary Last Modified 09/1999)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
18 and over
NCI
NCI-96-C-0139
NCI-NMOB-9305, NCI-T96-0058N, T96-0058
Last Modified:
4/20/2007
4.
Phase I Study of Recombinant Carcinoembryonic Antigen (CEA) Vaccinia Virus Vaccine With Post Vaccination CEA Peptide Challenge in Patients With Malignant Solid Tumors (Summary Last Modified 04/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Completed
over 18
NCI
MUSC-6124
NCI-T95-0044, T95-0044
Last Modified:
12/27/2008
 
First Published:
8/1/1999
5.
Phase I Pilot Adjuvant Study of Immunological Parameters Associated With Skin Testing and Vaccination With Autologous Lung Tumor Associated Antigen Plus DetoxPC in Patients With Curatively Resected Stage I, II, or IIIA Non-Small Cell Lung Cancer or Stage I or II Mesothelioma (Summary Last Modified 08/1999)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
20 to 70
NCI
RPCI-DS-96-25
NCI-G99-1551, NCT00003974
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute